clinically isolated syndrome
Showing 1 - 25 of >10,000
Clinically Isolated Syndrome, Radiologically Isolated Syndrome, Multiple Sclerosis in Children Trial in Lomme (Tear collection
Recruiting
- Clinically Isolated Syndrome
- +2 more
- Tear collection and lumbar punction
-
Lomme, FranceGHICL
Jan 5, 2022
Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis Trial in Iowa City (Therapeutic diet and lifestyle)
Active, not recruiting
- Clinically Isolated Syndrome
- Relapsing Remitting Multiple Sclerosis
- Therapeutic diet and lifestyle
-
Iowa City, IowaUniversity of Iowa
Dec 14, 2021
MSPT Device in Routine Clinical Practice in Swiss Healthcare
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
- MSPT
-
Bern, SwitzerlandInselspital Bern, Ambulantes Neurozentrum
Nov 1, 2022
Ocrelizumab in Breastmilk
Active, not recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 21, 2022
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in
Active, not recruiting
- Multiple Sclerosis
- +2 more
- Understanding MRI in MS (website)
- Control website
-
Hamburg, GermanyUniversity Medical Centre Hamburg-Eppendorf
Dec 5, 2022
Multiple Sclerosis Trial in Bordeaux (Clinical assessment, Neuropsychological evaluation, Psychological evaluation)
Recruiting
- Multiple Sclerosis
- Clinical assessment
- +3 more
-
Bordeaux, FranceCHU de Bordeaux - service de neurologie
Jun 15, 2022
Implementation ofNovel Functional Eye-Tracking Biomarker for
Recruiting
- Clinically Isolated Syndrome
- Relapsing Remitting Multiple Sclerosis
- Eye-tracking
-
Montréal, Quebec, CanadaMontreal Neurological Institute and Hospital
Sep 2, 2022
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine
Not yet recruiting
- Demyelinating Diseases
- +4 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023
Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination Trial (Tysabri Injectable Product, Placebo)
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome of Demyelination
- Tysabri Injectable Product
- Placebo
-
London, United KingdomRoyal London Hospital
Jan 25, 2023
Multiple Sclerosis, Clinically Isolated Syndrome Trial in Iowa City (Immediate Autoimmune Intervention Mastery Course (AIM),
Active, not recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
- Immediate Autoimmune Intervention Mastery Course (AIM)
- +3 more
-
Iowa City, IowaUniveristy of Iowa
Jul 3, 2022
Multiple Sclerosis, Clinically Isolated Syndrome (CIS) Trial in New York, Pittsburgh (Prebiotics (Prebiotin Prebiotic Fiber
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome (CIS)
- Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)
- Probiotics (Visbiome®)
-
New York, New York
- +1 more
Jan 5, 2022
Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in San Francisco (Ocrelizumab)
Recruiting
- Relapsing Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, CaliforniaUniversity of California San Francisco
Apr 28, 2022
Automatic Segmentation Software to Track Lesions in Multiple
Active, not recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
- Analysis of cerebral MRI with automatic segmentation software
-
Nîmes, FranceCHU Nimes
Dec 15, 2021
Multiple Sclerosis, Clinically Isolated Syndrome Trial in Bordeaux (blood sample, cerebro-spinal fluid)
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
- blood sample
- cerebro-spinal fluid
-
Bordeaux, FranceCHU de Bordeaux - service de neurologie
Feb 2, 2022
Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, California
- +5 more
Aug 2, 2022
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Beirut (Vitamin D3)
Recruiting
- Multiple Sclerosis
- +4 more
- Vitamin D3
-
Beirut, LebanonNehme & Therese Tohme Multiple Sclerosis Center
Aug 27, 2021
Visual Processing Speed and Objective Analysis of Ocular
Enrolling by invitation
- Multiple Sclerosis
- +3 more
- Eye tracking
- +3 more
-
Valladolid, SpainIOBA - Universidad de Valladolid
Jan 20, 2023
CNS Inflammatory Demyelinating Diseases
Not yet recruiting
- Multiple Sclerosis
- +4 more
- Intravenous steroid
- (no location specified)
Nov 29, 2021
MS-ResearchBiomarkerS
Recruiting
- Multiple Sclerosis
- +10 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 26, 2022
Pregnancy Cohort in Multiple Sclerosis (MS)
Recruiting
- Multiple Sclerosis (MS)
- Clinically Isolated Syndrome (CIS)
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Aug 17, 2021
Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, California
- +9 more
Aug 2, 2022
Risk Factors in Early Multiple Sclerosis
Recruiting
- Multiple Sclerosis
- +4 more
- Brain MRI
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Aug 4, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in Sweden (Rituximab, Dimethyl fumarate, Sodium Chloride solution)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- Rituximab
- +2 more
-
Borås, Sweden
- +16 more
Oct 11, 2021
Multiple Sclerosis Trial in France (drug, other, biological)
Active, not recruiting
- Multiple Sclerosis
- Vitamin D
- +5 more
-
Amiens Cedex 1, France
- +32 more
Jan 6, 2022
Emotional Processing in Multiple Sclerosis / Clinically Isolated
Completed
- Multiple Sclerosis (MS)
- Clinically Isolated Syndrome (CIS)
-
Berlin, GermanyCharité Unversitätsmedizin Berlin; NeuroCure Clinical Research C
Jul 15, 2020